The effects of sertraline on blood lipids, glucose, insulin and HBA1C levels: A prospective clinical trial on depressive patients


Kesim M., Tiryaki A., Kadioglu M., MUCI E., KALYONCU N. İ. , YARIŞ E.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES, vol.16, no.12, pp.1525-1531, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 12
  • Publication Date: 2011
  • Journal Name: JOURNAL OF RESEARCH IN MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.1525-1531
  • Keywords: Sertraline, Insulin, Glucose, Lipid, HbA1C, SEROTONIN REUPTAKE INHIBITORS, DISORDER, ANTIDEPRESSANTS, SENSITIZATION, CHOLESTEROL, FLUOXETINE, GLYCEMIA, SUCROSE, MEAL, RATS

Abstract

BACKGROUND: In this study, we aimed to investigate the possible effects of sertraline on blood glucose and lipid levels as risk factors for cardiovascular disease in depressive patients.